UCLA Biodesign: Innovations in Patient Care

UCLA Biodesign, the multidisciplinary fellowship program focusing on all areas that impact health products, was featured in the November/December 2020 issue of Diversity in Action.

The UCLA Biodesign fellowship program offers participants the opportunity to immerse themselves for one year in UCLA’s world-class health system as they’re taught to identify clinical needs, ideate and innovate new products to meet those needs and then bring those products and solutions to market.

Fellows come to the program with backgrounds not only in medicine but also in business, design, engineering and computer science, all with a goal of developing transformational biotechnologies- from wearables to sensors, to diagnostics and digital therapeutics- from which doctors, patients and health systems can benefit.

The first cohort graduated in June 2020, and the second cohort kicked off course work in the fall, navigating a health care landscape forever altered by COVID.

The UCLA Biodesign program is co-directed by Dr. Jennifer McCaney and Desert Horse-Grant.

You can read the full article here and learn more about UCLA Biodesign here.

Previous
Previous

New Cedars-Sinai Biomanufacturing Center to Spur Cell Therapies

Next
Next

UCLA receives $7.3 million grant to build state-of-the-art facility for developing gene, cell therapies